Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.
Cancer Immunol Res. 2017 Jun;5(6):480-492. doi: 10.1158/2326-6066.CIR-16-0329. Epub 2017 May 18.
Cancer Immunol Res. 2017.
PMID: 28522460
Free PMC article.
Clinical Trial.